| 2vtb |
Structure of cryptochrome 3 - DNA complex |
3 |
3 |
X-RAY DIFFRACTION |
| 2vtc |
The structure of a glycoside hydrolase family 61 member, Cel61B from the Hypocrea jecorina. |
2 |
2 |
X-RAY DIFFRACTION |
| 2vtd |
Crystal structure of MurD ligase in complex with D-Glu containing sulfonamide inhibitor |
1 |
1 |
X-RAY DIFFRACTION |
| 2vte |
Crystal structure of MurD ligase in complex with D-Glu containing sulfonamide inhibitor |
1 |
1 |
X-RAY DIFFRACTION |
| 2vtf |
X-ray crystal structure of the Endo-beta-N-acetylglucosaminidase from Arthrobacter protophormiae E173Q mutant reveals a TIM barrel catalytic domain and two ancillary domains |
2 |
2 |
X-RAY DIFFRACTION |
| 2vtg |
Crystal Structure of Human Iba2, trigonal crystal form |
1 |
1 |
X-RAY DIFFRACTION |
| 2vth |
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design |
1 |
1 |
X-RAY DIFFRACTION |
| 2vti |
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. |
1 |
1 |
X-RAY DIFFRACTION |
| 2vtj |
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design |
1 |
1 |
X-RAY DIFFRACTION |
| 2vtk |
THYMIDINE KINASE FROM HERPES SIMPLEX VIRUS TYPE 1 IN COMPLEX WITH ADP AND DEOXYTHYMIDINE |
1 |
1 |
X-RAY DIFFRACTION |
| 2vtl |
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design |
1 |
1 |
X-RAY DIFFRACTION |
| 2vtm |
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. |
1 |
1 |
X-RAY DIFFRACTION |
| 2vtn |
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. |
1 |
1 |
X-RAY DIFFRACTION |
| 2vto |
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. |
1 |
1 |
X-RAY DIFFRACTION |
| 2vtp |
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. |
1 |
1 |
X-RAY DIFFRACTION |
| 2vtq |
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. |
1 |
1 |
X-RAY DIFFRACTION |
| 2vtr |
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design |
1 |
1 |
X-RAY DIFFRACTION |
| 2vts |
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. |
1 |
1 |
X-RAY DIFFRACTION |
| 2vtt |
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. |
1 |
1 |
X-RAY DIFFRACTION |
| 2vtu |
crystal structure of bacteriophage MS2 covalent coat protein dimer |
2 |
6 |
X-RAY DIFFRACTION |
| 2vtv |
PhaZ7 depolymerase from Paucimonas lemoignei |
2 |
2 |
X-RAY DIFFRACTION |
| 2vtw |
Structure of the C-terminal head domain of the fowl adenovirus type 1 short fibre |
2 |
2 |
X-RAY DIFFRACTION |
| 2vtx |
ACTIVATION OF NUCLEOPLASMIN, AN OLIGOMERIC HISTONE CHAPERONE, CHALLENGES ITS STABILITY |
2 |
2 |
X-RAY DIFFRACTION |
| 2vty |
Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain swapped dimer |
1 |
1 |
X-RAY DIFFRACTION |
| 2vtz |
Biosynthetic thiolase from Z. ramigera. Complex of the C89A mutant with coenzyme A. |
1 |
1 |
X-RAY DIFFRACTION |
| 2vu0 |
Biosynthetic thiolase from Z. ramigera. Complex of the oxidised enzyme with coenzyme A. |
1 |
1 |
X-RAY DIFFRACTION |
| 2vu1 |
Biosynthetic thiolase from Z. ramigera. Complex of with O-pantheteine- 11-pivalate. |
1 |
1 |
X-RAY DIFFRACTION |
| 2vu2 |
Biosynthetic thiolase from Z. ramigera. Complex with S-pantetheine-11- pivalate. |
1 |
1 |
X-RAY DIFFRACTION |
| 2vu3 |
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. |
1 |
1 |
X-RAY DIFFRACTION |
| 2vu4 |
Structure of PsbP protein from Spinacia oleracea at 1.98 A resolution |
1 |
1 |
X-RAY DIFFRACTION |
| 2vu5 |
Crystal structure of Pndk from Bacillus anthracis |
1 |
1 |
X-RAY DIFFRACTION |
| 2vu6 |
Atomic resolution (0.95 A) structure of purified Thaumatin I grown in sodium meso-tartrate at 19 C. |
1 |
1 |
X-RAY DIFFRACTION |
| 2vu7 |
Atomic resolution (1.08 A) structure of purified thaumatin I grown in sodium meso-tartrate at 4 C |
1 |
1 |
X-RAY DIFFRACTION |
| 2vu8 |
Crystal structure of an insect inhibitor with a fungal trypsin |
1 |
1 |
X-RAY DIFFRACTION |
| 2vu9 |
CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE A BINDING DOMAIN IN COMPLEX WITH GT1B |
1 |
1 |
X-RAY DIFFRACTION |
| 2vua |
Crystal Structure of the Botulinum Neurotoxin Serotype A binding domain |
1 |
1 |
X-RAY DIFFRACTION |
| 2vub |
CCDB, A TOPOISOMERASE POISON FROM E. COLI |
1 |
1 |
X-RAY DIFFRACTION |
| 2vuc |
PA-IIL lectin from Pseudomonas aeruginosa complexed with Fucose- derived glycomimetics |
1 |
1 |
X-RAY DIFFRACTION |
| 2vud |
PA-IIL lectin from pseudomonas aeruginosa complexed with fucose- derived glycomimetics |
1 |
1 |
X-RAY DIFFRACTION |
| 2vue |
Human serum albumin complexed with 4Z,15E-bilirubin-IX-alpha |
2 |
2 |
X-RAY DIFFRACTION |
| 2vuf |
Human serum albumin complexed with fusidic acid |
2 |
2 |
X-RAY DIFFRACTION |
| 2vug |
The structure of an archaeal homodimeric RNA ligase |
1 |
1 |
X-RAY DIFFRACTION |
| 2vuh |
Crystal structure of the D55E mutant of the HupR receiver domain |
1 |
1 |
X-RAY DIFFRACTION |
| 2vui |
Crystal structure of the HupR receiver domain in inhibitory phospho- state |
1 |
1 |
X-RAY DIFFRACTION |
| 2vuj |
Environmentally isolated GH11 xylanase |
1 |
1 |
X-RAY DIFFRACTION |
| 2vuk |
Structure of the p53 core domain mutant Y220C bound to the stabilizing small-molecule drug PhiKan083 |
2 |
2 |
X-RAY DIFFRACTION |
| 2vul |
Thermostable mutant of ENVIRONMENTALLY ISOLATED GH11 XYLANASE |
1 |
1 |
X-RAY DIFFRACTION |
| 2vum |
Alpha-amanitin inhibited complete RNA polymerase II elongation complex |
1 |
1 |
X-RAY DIFFRACTION |
| 2vun |
The Crystal Structure of Enamidase at 1.9 A Resolution - A new Member of the Amidohydrolase Superfamily |
1 |
1 |
X-RAY DIFFRACTION |
| 2vuo |
Crystal structure of the rabbit IgG Fc fragment |
1 |
1 |
X-RAY DIFFRACTION |